The Asia Pacific Protein A Resin Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).
The Protein A affinity chromatography method is largely utilized in labs to obtain & purify immunoglobulins, like monoclonal antibody products & IgG. The procedure operates on the concept of the tying of particular antibodies to deactivate Protein A ligands. Throughout the assay, Protein A resin is connected to 4% agarose, following which the tying is optimized to attain an increased binding ability of immunoglobulins. Various factors regulate the dynamic binding ability of the resin to antibodies, like target antibody and flow rate.
Immunoprecipitation is an affinity purification method for antigens. In this method, the antibodies are disabled on the agarose resin exterior, which enables their efficient binding with particular antigens is there in the solution. Protein A Resin utilizes purified antibodies in a sandwich pattern to purify proteins, antigenic molecules, & complexes. Furthermore, it helps in precipitating antibodies from different complex mixtures.
Japan is an extremely industrialized country whose economy is mainly constructed on science & technology. In 2017, the nation had a more advanced technology supply throughout the world, with above 1,060 million engineers and scientists. In addition, the pharmaceutical industry and business enterprises recruited more than 586,000 technicians and researchers, nationwide. For several decades, Japan has been one of the world leaders in expending on patent applications, scientific publications, and R&D. It has been observed that the increase in the pharmaceutical sector. This development of the healthcare sector has increased the usage of protein A resins across the pharma and biopharma industry. This will result in the growth of protein A resin market in the upcoming years.
The China market dominated the Asia Pacific Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $142 million by 2028.The Japan market is estimated to grow a CAGR of 6.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 7.6% during (2022 - 2028).
Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Protein A Resin Market is Projected to reach USD 1.9 Billion by 2028, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).
By Product Type
By End Use
By Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 